Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Quince Therapeutics, Inc. | 19,547 | reported | 02 Jan 2026 | tx 24+288,679−14,550 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Quince Therapeutics, Inc. | 19,547 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 31,613 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 08 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 8,000 | 1.23 USD | first after silence |
| 24 May 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 08 Oct 2021 | SALE | Quince Therapeutics, Inc. | 1,000 | 88.93 USD | |
| 08 Oct 2021 | EXERCISE | Quince Therapeutics, Inc. | 1,000 | 17.00 USD | |
| 08 Oct 2021 | EXERCISE | Quince Therapeutics, Inc. | 1,000 | 0.00 USD | deriv |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 423 | 97.55 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 1,429 | 96.51 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 1,044 | 95.57 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 3,056 | 94.55 USD | |
| 16 Aug 2021 | EXERCISE | Quince Therapeutics, Inc. | 6,000 | 17.00 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 48 | 98.90 USD | |
| 16 Aug 2021 | EXERCISE | Quince Therapeutics, Inc. | 6,000 | 0.00 USD | deriv |
| 28 Jun 2021 | SALE | Quince Therapeutics, Inc. | 200 | 55.01 USD | |
| 28 Jun 2021 | SALE | Quince Therapeutics, Inc. | 250 | 55.03 USD | |
| 28 Jun 2021 | SALE | Quince Therapeutics, Inc. | 100 | 55.73 USD | |
| 16 Jun 2021 | GRANT_AWARD | Quince Therapeutics, Inc. | 11,029 | 0.00 USD | deriv |
| 08 Jun 2020 | GRANT_AWARD | Quince Therapeutics, Inc. | 11,029 | 0.00 USD | deriv |
| 13 May 2019 | PURCHASE | Quince Therapeutics, Inc. | 550 | 17.00 USD | |
| 08 May 2019 | GRANT_AWARD | Quince Therapeutics, Inc. | 91,911 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 Aug 2023.